Cisplatin - Medicow
About us  |  Why use us?  |  Press  |  Contact us

 

Topic: Cisplatin



  
 Cisplatin (PIM 132)
Ototoxicity, as induced by cisplatin, is cumulative so therapy is contraindicated in patients with pre-existing hearing impairments.
Cisplatin is carcinogenic in animals so care must be exercised in regards to handling cisplatin and wastes associated with patients receiving cisplatin.
Breastfeeding is not recommended during cisplatin therapy due to potential risk to the infant (Briggs et al., 1990).
http://www.intox.org/databank/documents/pharm/cisplat/cisplat.htm   (7652 words)

  
 Cisplatin - Wikipedia, the free encyclopedia
This study found that cis-diamminedichloroplatinum(II) was the most effective out of this group, which started the medicinal career of cisplatin.
Cisplatin: The Invention of an Anticancer Drug by Andri Smith
Neurotoxicity (nerve damage) can be anticipated by performing nerve conduction studies before and after treatment.
http://en.wikipedia.org/wiki/Cisplatin   (505 words)

  
 Cisplatin and DNA repair in cancer chemotherapy
The mechanisms by which cells develop resistance to cisplatin is an area of intense research because it is one of the major impediments to the clinical success of this drug.
Cisplatin is indicated as palliative therapy to be employed against: Metastatic testicular tumors - Most effective
There are two major limitations to Cisplatin therapy:
http://bioweb.wku.edu/courses/Biol588/Bishopl.html   (997 words)

  
 MedlinePlus Drug Information: Cisplatin (Systemic)
Cisplatin is to be administered only by or under the immediate supervision of your doctor.
While you are being treated with cisplatin, and after you stop treatment with it, do not have any immunizations (vaccinations) without your doctor's approval.
Before you begin treatment with cisplatin, you and your doctor should talk about the good this medicine will do as well as the risks of using it.
http://www.nlm.nih.gov/medlineplus/druginfo/uspdi/202143.html   (1890 words)

  
 MedlinePlus Drug Information: Cisplatin
Talk to your doctor about the possible risks of using this drug for your condition.
This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.
tell your doctor and pharmacist if you are allergic to cisplatin or any other platinum-containing compounds such as carboplatin (Paraplatin, CBDCA) or any other drugs.
http://www.nlm.nih.gov/medlineplus/druginfo/medmaster/a684036.html   (588 words)

  
 Down-regulation of Bcl-2 is associated with cisplatin resistance in human small cell lung cancer H69 cells -- Kumar ...
Because cisplatin is the drug of choice for the treatment of
cisplatin for 0, 24, 48, and 72 h, stained with propidium iodide and analyzed using a flow cytometer as described under Materials and Methods.
such as Bax or Bak, was associated with cisplatin resistance.
http://mct.aacrjournals.org/cgi/content/full/3/3/327   (3801 words)

  
 Cisplatin
Cisplatin is a chemotherapy drug used to treat some forms of cancer.
People receiving cisplatin chemotherapy should ask their prescribing doctor to closely monitor magnesium and potassium status.
Silymarin has not yet been studied in humans treated with cisplatin.
http://www.a1nutritionproducts.com/health/Drug/Cisplatin.htm   (3419 words)

  
 Cisplatin Sensitivity in Hmgb1-/- and Hmgb1+/+ Mouse Cells -- Wei et al. 278 (3): 1769 -- Journal of Biological ...
The goal of this study was to explore the connection between HMGB1 levels and the sensitivity of mammalian cells to cisplatin.
cisplatin is a subject of much current interest.
cisplatin sensitivity was also observed in a lung adenocarcinoma
http://www.jbc.org/cgi/content/full/278/3/1769   (3066 words)

  
 Cisplatin factsheet
This fact sheet explains what Cisplatin is, how it is given and some of the possible side effects.
Strange taste: It is possible that your child may experience a strange taste whilst receiving cisplatin.
Your child may complain of aches and pains in their legs.
http://www.gosh.nhs.uk/factsheets/families/F990241   (723 words)

  
 cisplatin - [Medication]
Your doctor will determine the correct amount and frequency of treatment with cisplatin depending upon the type of cancer being treated and other factors.
If for any reason an overdose of cisplatin is suspected, seek emergency medical attention or contact your healthcare provider immediately.
Your doctor will probably want you to have regularly scheduled blood tests and other medical evaluations during treatment with cisplatin to monitor progress and side effects.
http://www.peacehealth.org/kbase/multum/d00195a1.htm   (950 words)

  
 From the Cover: Uptake of the anticancer drug cisplatin mediated by the copper transporter Ctr1 in yeast and mammals -- ...
Cisplatin is a chemotherapeutic drug used to treat a variety of
to affect levels of resistance to cisplatin by sequestering
Deletion of CTR2 or FET4 did not affect cisplatin resistance
http://www.pnas.org/cgi/content/full/99/22/14298   (3996 words)

  
 Cisplatin-Induced Hyperactivity in the Dorsal Cochlear Nucleus and Its Relation to Outer Hair Cell Loss: Relevance to ...
Cisplatin rescue therapy: experience with sodium thiosulfate, WR2721, and diethyldithiocarbamate.
by cisplatin offers to explain the chronic nature of tinnitus
An aspect of our results that needs to be reconciled with the interpretation that hyperactivity in the DCN might be linked
http://jn.physiology.org/cgi/content/full/88/2/699   (8903 words)

  
 A Novel Free Radical Scavenger, Edarabone, Protects Against Cisplatin-Induced Acute Renal Damage in Vitro and in Vivo ...
Lebwohl D and Canetta R (1998) Clinical development of platinum complexes in cancer therapy: an historical perspective and an update.
pathways were important in apoptosis induced by cisplatin
in Ccr was observed in the cisplatin treatment group versus
http://jpet.aspetjournals.org/cgi/content/full/305/3/1183   (4281 words)

  
 Phase III Study of Pemetrexed in Combination With Cisplatin Versus Cisplatin Alone in Patients With Malignant Pleural ...
Thodtmann R, Depenbrock H, Dumez H, et al: Clinical and pharmacokinetic phase I study of multitargeted antifolate (LY231514) in combination with cisplatin.
Samson MK, Wasser LP, Borden EC, et al: Randomized comparison of cyclophosphamide, imidazole carboxamide, and adriamycin versus cyclophosphamide and adriamycin in patients with advanced stage malignant mesothelioma: A Sarcoma Intergroup study.
does not overlap that of cisplatin (gastrointestinal, neurological,
http://www.jco.org/cgi/content/full/21/14/2636   (5515 words)

  
 Cisplatin
You may not be able to get pregnant or father a child after taking this medication.
Eye problems, such as blurred vision or loss of the ability to see colors.
Cisplatin is an intravenous (IV) medication usually given in a dose that is based on body surface area.
http://www.webmd.com/hw/cancer/tv6626.asp   (327 words)

  
 Weekly Irinotecan and Cisplatin in Advanced Non-Small Cell Lung Cancer: A Multicenter Phase II Study -- Jagasia et al. ...
for NSCLC, the combination of CPT-11 with cisplatin in the therapy
Phase I studies of monthly cisplatin with weekly CPT-11
Weekly Irinotecan and Cisplatin in Advanced Non-Small Cell Lung Cancer: A Multicenter Phase II Study
http://clincancerres.aacrjournals.org/cgi/content/full/7/1/68   (3568 words)

  
 Methods of Treatment - Cisplatin - The Platinum Standard
Cisplatin, like Gertrude Elion's 6-MP, is an example of an anticancer treatment that was discovered by serendipity, by following the curious puzzles that arise in scientific investigations.
Both cisplatin and carboplatin currently are used to treat testicular and ovarian cancer.
Cisplatin, as Rosenberg dubbed cis-diamminedichloroplatinum, was approved for use as a cancer drug in 1978.
http://chemheritage.org/EducationalServices/pharm/chemo/readings/cisplat.htm   (939 words)

  
 Product Label
Cisplatin showed meaningful response rate in 7 studies as a sinle therapy for testicular tumors, in three studies as a combination therapy for testicular tumors and in two studies as a single or combination therapy for ovarian tumors.
FDA Oncology Tools Approval Summary for cisplatin for Metastatic testicular-in established combination therapy with other approved chemotherapeutic agents in patients with metastatic testicular tumors whoc have already received appropriate surgical and/or radiotherapeutic procedures.
Royal Morsdem Hospital study: 52 pts cisplatin alone RR 32%, cisplatin/hydration/mannitol 18% cr, 45% PR..
http://www.accessdata.fda.gov/scripts/cder/onctools/summary.cfm?ID=71   (237 words)

  
 The Synergistic Cytotoxicity of Cisplatin and Taxol in Killing Oral Squamous Cell Carcinoma -- Huang et al. 34 (9): 499 ...
Although carboplatin is thought to be a better choice than cisplatin
Oral and Maxillofacial Surgery Section, Chi-Mei Medical Center, Tainan,
Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck: the Dana Farber Cancer Institute experience.
http://jjco.oxfordjournals.org/cgi/content/full/34/9/499   (2374 words)

  
 Evolution of Cisplatin-Based Chemotherapy in Non-Small Cell Lung Cancer : A Historical Perspective and The Eastern ...
Prior to 1990, only a few drugs (including cisplatin, mitomycin
carboplatin for cisplatin in the treatment of NSCLC patients.
Given these observations, it is appropriate today for patients
http://www.chestjournal.org/cgi/content/full/117/4_suppl_1/133S   (2719 words)

  
 News - Irinotecan/Cisplatin Combination Aids Lung Cancer Patients
This is the finding of a multicentre study in Japan conducted by Kazumasa Noda and colleagues for the Japan Clinical Oncology Group.
Irinotecan plus cisplatin is an effective treatment for metastatic small-cell lung cancer.
There was a high response rate and a promising median survival time in an earlier phase two study of irinotecan plus cisplatin in patients with extensive small-cell lung cancer.
http://docguide.com/news/content.nsf/news/8525697700573E1885256B3D004EBB04   (440 words)

  
 Carboplatin Equals Cisplatin: But How Do I Prescribe It? -- Gore 21 (17): 3183 -- Journal of Clinical Oncology
McGuire WP, Hoskins WJ, Brady MF, et al: Assessment of dose-intensive therapy in suboptimally debulked ovarian cancer: A Gynecologic Oncology Group study.
carboplatin for cisplatin in patients who had suboptimally debulked,
patients were treated with carboplatin plus paclitaxel or cisplatin
http://www.jco.org/cgi/content/full/21/17/3183   (2331 words)

  
 A pilot study of CPT-11 and cisplatin for ovarian clear cell adenocarcinoma -- Adachi et al. 29 (9): 434 -- Japanese ...
Combination of irinotecan hydrochloride (CPT-11) and cisplatin as a new regimen for patients with ovarian cancer.
Irinotecan (CPT-11) combined with cisplatin in patients with refractory or recurrent ovarian cancer.
Cyclophosphamide plus cisplatin has been the standard therapy for ovarian cancer, but ovarian clear cell adenocarcinoma dose not respond to this therapy.
http://jjco.oxfordjournals.org/cgi/content/full/29/9/434   (2451 words)

  
 ChemCases: Cisplatin - 17. Drug Resistance
Even though cisplatin has proven to be a highly effective chemotherapeutic agent for treating various types of cancers, it has encountered the same fate as many other drugs used in cancer chemotherapy—namely, drug resistance.
Furthermore, in one case, a patient was treated with carboplatin, a close relative of cisplatin (see below); carboplatin was initially effective in treating the patient’s tumor, but resistance to this drug eventually occurred.
Therefore, it is beneficial for the cancer cell to develop mechanisms either to keep cisplatin out of the cell or to remove cisplatin from the cell; indeed, reducing cisplatin accumulation by cancer cells seems to be a major form of acquired resistance.
http://science.kennesaw.edu/~mhermes/cisplat/cisplat17.htm   (797 words)

  
 ChemCases: Cisplatin - 13. Recent Developments
Once a successful drug has been discovered for the treatment of a particular disease or condition, researchers will often try to improve on that drug by synthesizing and studying related compounds, referred to as analogs or second-generation drugs.
Researchers believe that these third-generation drugs are more effective than cisplatin because they are taken up into the cell in greater concentrations than cisplatin.
It would be impossible to describe all of that research here, so we will focus on just two areas of continuing study: the development of second- and third-generation drugs in the cisplatin family, and the research on the cellular target of cisplatin.
http://science.kennesaw.edu/~mhermes/cisplat/cisplat13.htm   (1142 words)

  
 NEJM -- Irinotecan plus Cisplatin Compared with Etoposide plus Cisplatin for Extensive Small-Cell Lung Cancer
Phase I-II study of amrubicin and cisplatin in previously untreated patients with extensive-stage small-cell lung cancer.
Conclusions Irinotecan plus cisplatin is an effective treatment
the patients assigned to receive irinotecan and cisplatin and
http://content.nejm.org/cgi/content/abstract/346/2/85   (1472 words)

  
 cisplatin
Cisplatin (cis-diamminedichloroplatinum(II)) is a DNA damaging anticancer drug used most successfully for the treatment of testicular tumors.
Reference: Zdravesky, Z.Z., Mello, J.A., Marinus, M.G. and Essigmann, J.M. Multiple pathways of recombination define cellular responses to cisplatin.
Finally, cisplatin was found to be a potent recombinogen in comparison to the therapeutically inactive trans isomer.
http://users.umassmed.edu/martin.marinus/cisplatin.html   (1303 words)

  
 Cisplatin
on-line buy Cisplatin, free Cisplatin buy, order and buy Cisplatin tramadol prescription on line, purchase Cisplatin here, low cost Cisplatin,
pharmacy Cisplatin online, Cisplatin side effects, buy pill Cisplatin here, cheap online Cisplatin, information Cisplatin online,
discount Cisplatin online, buy Cisplatin order, Cisplatin online discount, Cisplatin information, side Cisplatin effects,
http://alkonaft.com/cat1/Cisplatin.html   (103 words)

 About us   |  Why use us?   |  Press   |  Contact us

 Copyright © 2006 Medicow.com Usage implies agreement with terms.